Baker Bros. Advisors

On late Tuesday, hedge fund Baker Bros. Advisors, managed by Julian and Felix Baker, filed two Schedule 13Ds with the SEC, disclosing moves in DBV Technologies SA - ADR (NASDAQ: DBVT) and Seattle Genetics, Inc. (NASDAQ: SGEN). The firm disclosed an increase in its stake in Seattle Genetics and a...

Shares of Aquinox Pharmaceuticals Inc (NASDAQ: AQXP) are surging on Monday. The surge was triggered by a new increase in the stake of biotech-focused hedge fund Baker Bros. Other hedge funds betting on the company are RA Capital Management and Broadfin Capital. Shares of Aquinox rose more than 4...

Shares of Aquinox Pharmaceuticals Inc (NASDAQ: AQXP) skyrocketed more than 350 percent Monday morning, hitting a 52-week high of $55.75. The stock was trading at less than $2 per share last Thursday -- that's not a typo. Midway through Monday's trading, the stock is near the $38 mark. On Friday...